We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lab Parameters Assessed for New Infectious Disease

By LabMedica International staff writers
Posted on 23 May 2017
Print article
Image: The FACS Canto II, an 8-color, flow cytometric analyzer (Photo courtesy of BD BioScience).
Image: The FACS Canto II, an 8-color, flow cytometric analyzer (Photo courtesy of BD BioScience).
Severe fever with thrombocytopenia syndrome (SFTS) is a newly emerging infectious disease and the etiological agent of SFTS has been revealed to be a novel phlebovirus in the family Bunyaviridae, termed severe fever with thrombocytopenia syndrome virus (SFTSV).

Laboratory tests on serum samples of SFTS patients commonly showed elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and creatine kinase (CK). However viral interaction with the innate immune system played a core role in determining the outcomes of the infection.

Scientists at the Jinan Infectious Diseases Hospital enrolled 69 patients (33 males and 36 females), with confirmed SFTSV infection, between May 2014 and September 2015. These patients were aged between 40 and 78 years. They were divided into two groups, recovery group and poor prognosis group, according to the clinical prognosis of the diseases. Serum anti-SFTSV immunoglobulin M (IgM) and SFTSV ribonucleic acid (RNA) were positive in all infected patients. In addition, 25 healthy volunteers (16 males and 9 females) were also enrolled in this study to serve as normal controls.

Blood cell and platelet counts were measured by a fully automatic blood cell analyzer. A fully automatic biochemical detector was used to determine levels of ALT, AST, LDH, and CK. The peripheral blood samples were processed for an analysis of lymphocyte subsets by flow cytometry within two hours. Lymphocyte subsets were identified by monoclonal antibodies and after processing cells were analyzed with FACS Canto Flow Cytometer and CellQuest software.

The team reported that the clinical manifestations typically became worse on about the 7th day. Most of them had multi-organ dysfunction, and part of them had hemophagocytic lymphohistiocytosis histiocytosis (HLH). The characteristic laboratory findings in the early stage were the drop of platelets (PLT), while the increase of ALT, AST, CK, LDH. SFTSV viral loads reached the highest on days 7 to 10 after onset of fever in SFTS patients. The CD3+, CD3 + CD4+ T cell counts were significantly reduced in poor prognosis group, more so on days 7 to 10 after onset of fever. CD3–/CD19+ (B cell) counts in SFTS patients were significantly higher than that of healthy controls. Eleven days after illness onset, symptoms were improved, accompanied by resolution of laboratory abnormalities.

The authors concluded that their results indicated that SFTS had an acute onset and self-limited course and it was a systemic infection. The host immune response caused tissues and organs injury. The improvement of symptoms and laboratory tests was consistent with the elimination of the virus and recovery of immune response. The study was published in the May 2017 issue of the International Journal of Infectious Diseases.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.